| Nassir Hassan Monim Mansour, MD | |
|
6001 E Broad St, Columbus, OH 43213-1502 | |
| (614) 546-4621 | |
| (614) 546-4536 |
| Full Name | Nassir Hassan Monim Mansour |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 19 Years |
| Location | 6001 E Broad St, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790923951 | NPI | - | NPPES |
| 036-134334 | Other | IL | STATE LICENSE |
| 35.144360 | Other | OH | LICENSE |
| 285013 | Other | NY | LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wyckoff Heights Medical Center | Brooklyn, NY | Hospital |
| Mount Carmel East & West | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wyckoff Professional Medical Services Pc | 6406748607 | 145 |
| Mount Carmel Health Providers Two Llc | 6608828447 | 214 |
News Archive
When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.
Catamaran Corp., a leading provider of pharmacy benefit management services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
› Verified 5 days ago
| Entity Name | Brookdale Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720028772 PECOS PAC ID: 4284545799 Enrollment ID: O20031120000600 |
News Archive
When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.
Catamaran Corp., a leading provider of pharmacy benefit management services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
› Verified 5 days ago
| Entity Name | Wyckoff Professional Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659710796 PECOS PAC ID: 6406748607 Enrollment ID: O20040324001805 |
News Archive
When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.
Catamaran Corp., a leading provider of pharmacy benefit management services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nassir Hassan Monim Mansour, MD 6001 E Broad St, Columbus, OH 43213-1502 Ph: (614) 546-4621 | Nassir Hassan Monim Mansour, MD 6001 E Broad St, Columbus, OH 43213-1502 Ph: (614) 546-4621 |
News Archive
When migraine sufferers see the tell-tale squiggly lines, light flashes and blind spots of a migraine aura, they prepare for a migraine.
Catamaran Corp., a leading provider of pharmacy benefit management services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
› Verified 5 days ago
Dr. Mynor Mendez Valdez, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 W 10th Ave Fl 12, Columbus, OH 43210 Phone: 440-975-6868 | |
Douglas A. Hardesty, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8714 Fax: 614-293-4281 | |
Michael J Meagher, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 931 Chatham Ln, Columbus, OH 43221 Phone: 614-533-5500 Fax: 614-533-5593 | |
Sigurdur A Stephensen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 931 Chatham Ln, Columbus, OH 43221 Phone: 614-457-4880 Fax: 614-457-4890 | |
Dr. Vikram Badhri Chakravarthy, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8714 Fax: 614-293-4281 | |
Dr. Andrew James Grossbach, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 543 Taylor Ave, Columbus, OH 43203 Phone: 614-293-8714 Fax: 614-293-4281 | |
Dr. Gregory W. Balturshot, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3525 Olentangy River Rd, Suite 5310, Columbus, OH 43214 Phone: 614-261-0073 Fax: 614-268-5611 |